Literature DB >> 30480430

Phospho-Tau Impairs Nuclear-Cytoplasmic Transport.

Timir Tripathi1, Jay Prakash1, Yaron Shav-Tal2.   

Abstract

Aggregation of hyperphosphorylated tau is the hallmark of several tauopathies, including Alzheimer's disease (AD). Although the mechanism underlying tau-associated neuronal damage remains unclear, it is believed that tau hyperphosphorylation is one of the key features in disease progression. A recent study demonstrates that hyperphosphorylated tau (P-tau) interacts with components of the nuclear pore complex (NPC) to impair nuclear-cytoplasmic transport and contribute to tau-induced neurotoxicity. The NPC thus represents a point of convergence between pathological tau and neuronal dysfunction in AD.

Entities:  

Keywords:  Alzheimer’s disease; NPC structure; Nuclear pore complex; aggregation; hyperphosphorylated tau; nuclear-cytoplasmic transport; nucleoporins; tauopathies

Year:  2018        PMID: 30480430     DOI: 10.1021/acschemneuro.8b00632

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  5 in total

Review 1.  Liquid-liquid phase separation of tau: From molecular biophysics to physiology and disease.

Authors:  Sandeep K Rai; Adriana Savastano; Priyanka Singh; Samrat Mukhopadhyay; Markus Zweckstetter
Journal:  Protein Sci       Date:  2021-05-14       Impact factor: 6.725

Review 2.  Nuclear Envelope and Nuclear Pore Complexes in Neurodegenerative Diseases-New Perspectives for Therapeutic Interventions.

Authors:  Naomi Hachiya; Marta Sochocka; Anna Brzecka; Takuto Shimizu; Kazimierz Gąsiorowski; Katarzyna Szczechowiak; Jerzy Leszek
Journal:  Mol Neurobiol       Date:  2020-10-17       Impact factor: 5.590

3.  High-throughput screening of natural compounds and inhibition of a major therapeutic target HsGSK-3β for Alzheimer's disease using computational approaches.

Authors:  Rohit Shukla; Tiratha Raj Singh
Journal:  J Genet Eng Biotechnol       Date:  2021-05-04

4.  Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes.

Authors:  Mauro Montalbano; Elizabeth Jaworski; Stephanie Garcia; Anna Ellsworth; Salome McAllen; Andrew Routh; Rakez Kayed
Journal:  Front Mol Neurosci       Date:  2021-12-03       Impact factor: 5.639

Review 5.  Tau in the Pathophysiology of Parkinson's Disease.

Authors:  Lina Pan; Lanxia Meng; Mingyang He; Zhentao Zhang
Journal:  J Mol Neurosci       Date:  2021-01-18       Impact factor: 3.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.